Copyright © 2012 Mayra Silva Miranda et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

1. S. H. Kaufmann, “Fact and fiction in tuberculosis vaccine research: 10 years later,” The Lancet Infectious Diseases, vol. 11, no. 8, pp. 633–640, 2011. View at Publisher · View at Google Scholar · View at Scopus
2. P. Gonzalez-Cano, R. Mondragón-Flores, L. E. Sánchez-Torres et al., “Mycobacterium tuberculosis H37Rv induces ectosome release in human polymorphonuclear neutrophils,” Tuberculosis, vol. 90, no. 2, pp. 125–134, 2010. View at Publisher · View at Google Scholar · View at Scopus
3. D. O. Adams, “The granulomatous inflammatory response. A review,” American Journal of Pathology, vol. 84, no. 1, pp. 164–192, 1976. View at Scopus
4. M. Sandor, J. V. Weinstock, and T. A. Wynn, “Granulomas in schistosome and mycobacterial infections: a model of local immune responses,” Trends in Immunology, vol. 24, no. 1, pp. 44–52, 2003. View at Publisher · View at Google Scholar · View at Scopus
5. A. M. Cooper, K. D. Mayer-Barber, and A. Sher, “Role of innate cytokines in mycobacterial infection,” Mucosal Immunology, vol. 4, no. 3, pp. 252–260, 2011. View at Publisher · View at Google Scholar · View at Scopus
6. E. K. Jo, C. S. Yang, C. H. Choi, and C. V. Harding, “Intracellular signalling cascades regulating innate immune responses to mycobacteria: branching out from Toll-like receptors,” Cellular Microbiology, vol. 9, no. 5, pp. 1087–1098, 2007. View at Publisher · View at Google Scholar · View at Scopus
7. D. E. Kirschner, D. Young, and J. L. Flynn, “Tuberculosis: global approaches to a global disease,” Current Opinion in Biotechnology, vol. 21, no. 4, pp. 524–531, 2010. View at Publisher · View at Google Scholar · View at Scopus
8. M. Gonzalez-Juarrero, O. C. Turner, J. Turner, P. Marietta, J. V. Brooks, and I. M. Orme, “Temporal and spatial arrangement of lymphocytes within lung granulomas induced by aerosol infection with Mycobacterium tuberculosis,” Infection and Immunity, vol. 69, no. 3, pp. 1722–1728, 2001. View at Publisher · View at Google Scholar · View at Scopus
9. M. P. Puissegur, C. Botanch, J. L. Duteyrat, G. Delsol, C. Caratero, and F. Altare, “An in vitro dual model of mycobacterial granulomas to investigate the molecular interactions between mycobacteria and human host cells,” Cellular Microbiology, vol. 6, no. 5, pp. 423–433, 2004. View at Publisher · View at Google Scholar · View at Scopus
10. J. L. Flynn, J. Chan, and P. L. Lin, “Macrophages and control of granulomatous inflammation in tuberculosis,” Mucosal Immunology, vol. 4, no. 3, pp. 271–278, 2011. View at Publisher · View at Google Scholar · View at Scopus
11. K. K. Huynh, S. A. Joshi, and E. J. Brown, “A delicate dance: host response to mycobacteria,” Current Opinion in Immunology, vol. 23, no. 4, pp. 464–472, 2011. View at Publisher · View at Google Scholar · View at Scopus
12. T. A. Day, M. Koch, G. Nouailles et al., “Secondary lymphoid organs are dispensable for the development of T-cell-mediated immunity during tuberculosis,” European Journal of Immunology, vol. 40, no. 6, pp. 1663–1673, 2010. View at Publisher · View at Google Scholar · View at Scopus
13. J. M. Davis, H. Clay, J. L. Lewis, N. Ghori, P. Herbomel, and L. Ramakrishnan, “Real-time visualization of mycobacterium-macrophage interactions leading to initiation of granuloma formation in zebrafish embryos,” Immunity, vol. 17, no. 6, pp. 693–702, 2002. View at Publisher · View at Google Scholar · View at Scopus
14. E. Torrado, R. T. Robinson, and A. M. Cooper, “Cellular response to mycobacteria: balancing protection and pathology,” Trends in Immunology, vol. 32, no. 2, pp. 66–72, 2011. View at Publisher · View at Google Scholar · View at Scopus
15. J. M. Davis, D. A. Haake, and L. Ramakrishnan, “Leptospira interrogans stably infects zebrafish embryos, altering phagocyte behavior and homing to specific tissues,” PLoS Neglected Tropical Diseases, vol. 3, no. 6, article e463, 2009. View at Publisher · View at Google Scholar · View at Scopus
16. C. L. Cosma, O. Humbert, and L. Ramakrishnan, “Superinfecting mycobacteria home to established tuberculous granulomas,” Nature Immunology, vol. 5, no. 8, pp. 828–835, 2004. View at Publisher · View at Google Scholar · View at Scopus
17. J. G. Egen, A. G. Rothfuchs, C. G. Feng, N. Winter, A. Sher, and R. N. Germain, “Macrophage and T cell dynamics during the development and disintegration of mycobacterial granulomas,” Immunity, vol. 28, no. 2, pp. 271–284, 2008. View at Publisher · View at Google Scholar · View at Scopus
18. J. G. Egen, A. G. Rothfuchs, C. G. Feng, M. A. Horwitz, A. Sher, and R. N. Germain, “Intravital imaging reveals limited antigen presentation and T cell effector function in mycobacterial granulomas,” Immunity, vol. 34, no. 5, pp. 807–819, 2011. View at Publisher · View at Google Scholar · View at Scopus
19. D. O. Co, L. H. Hogan, S. Il-Kim, and M. Sandor, “T cell contributions to the different phases of granuloma formation,” Immunology Letters, vol. 92, no. 1-2, pp. 135–142, 2004. View at Publisher · View at Google Scholar
20. S. A. Khader, J. Rangel-Moreno, J. J. Fountain et al., “In a murine tuberculosis model, the absence of homeostatic chemokines delays granuloma formation and protective immunity,” Journal of Immunology, vol. 183, no. 12, pp. 8004–8014, 2009. View at Publisher · View at Google Scholar · View at Scopus
21. D. R. Roach, A. G. D. Bean, C. Demangel, M. P. France, H. Briscoe, and W. J. Britton, “TNF regulates chemokine induction essential for cell recruitment, granuloma formation, and clearance of mycobacterial infection,” Journal of Immunology, vol. 168, no. 9, pp. 4620–4627, 2002. View at Scopus
22. S. T. Reece, C. Loddenkemper, D. J. Askew et al., “Serine protease activity contributes to control of Mycobacterium tuberculosis in hypoxic lung granulomas in mice,” Journal of Clinical Investigation, vol. 120, no. 9, pp. 3365–3376, 2010. View at Publisher · View at Google Scholar · View at Scopus
23. J. Harper, C. Skerry, S. L. Davis et al., “Mouse model of necrotic tuberculosis granulomas develops hypoxic lesions,” Journal of Infectious Diseases, vol. 205, no. 4, pp. 595–602, 2012. View at Publisher · View at Google Scholar · View at Scopus
24. E. R. Driver, G. J. Ryan, D. R. Hoff, et al., “Evaluation of a mouse model of necrotic granuloma formation using C3HeB/FeJ mice for testing of drugs against Mycobacterium tuberculosis,” vol. 56, no. 6, pp. 3181–3195, 2012.
25. J. L. Flynn, “Lessons from experimental Mycobacterium tuberculosis infections,” Microbes and Infection, vol. 8, no. 4, pp. 1179–1188, 2006. View at Publisher · View at Google Scholar · View at Scopus
26. P. L. Lin, S. Pawar, A. Myers et al., “Early events in Mycobacterium tuberculosis infection in cynomolgus macaques,” Infection and Immunity, vol. 74, no. 7, pp. 3790–3803, 2006. View at Publisher · View at Google Scholar · View at Scopus
27. P. L. Lin, M. Rodgers, L. Smith et al., “Quantitative comparison of active and latent tuberculosis in the cynomolgus macaque model,” Infection and Immunity, vol. 77, no. 10, pp. 4631–4642, 2009. View at Publisher · View at Google Scholar · View at Scopus
28. M. Fallahi-Sichani, M. El-Kebir, S. Marino, D. E. Kirschner, and J. J. Linderman, “Multiscale computational modeling reveals a critical role for TNF-α receptor 1 dynamics in tuberculosis granuloma formation,” Journal of Immunology, vol. 186, no. 6, pp. 3472–3483, 2011. View at Publisher · View at Google Scholar · View at Scopus
29. S. Marino, M. El-Kebir, and D. Kirschner, “A hybrid multi-compartment model of granuloma formation and T cell priming in Tuberculosis,” Journal of Theoretical Biology, vol. 280, no. 1, pp. 50–62, 2011. View at Publisher · View at Google Scholar · View at Scopus
30. J. L. Segovia-Juarez, S. Ganguli, and D. Kirschner, “Identifying control mechanisms of granuloma formation during M. tuberculosis infection using an agent-based model,” Journal of Theoretical Biology, vol. 231, no. 3, pp. 357–376, 2004. View at Publisher · View at Google Scholar · View at Scopus
31. G. Magombedze and N. Mulder, “A mathematical representation of the development of Mycobacterium tuberculosis active, latent and dormant stages,” Journal of Theoretical Biology, vol. 292, pp. 44–59, 2012. View at Publisher · View at Google Scholar
32. F. C. Zucchi, A. Pelegrini-da-Silva, L. Neder, C. L. Silva, A. M. C. Tsanaclis, and O. M. Takayanagui, “The contribution of a murine CNS-TB model for the understanding of the host-pathogen interactions in the formation of granulomas,” Journal of Neuroscience Methods, vol. 206, no. 1, pp. 88–93, 2012. View at Publisher · View at Google Scholar · View at Scopus
33. G. Lay, Y. Poquet, P. Salek-Peyron et al., “Langhans giant cells from M. Tuberculosis-induced human granulomas cannot mediate mycobacterial uptake,” Journal of Pathology, vol. 211, no. 1, pp. 76–85, 2007. View at Publisher · View at Google Scholar · View at Scopus
34. P. Peyron, J. Vaubourgeix, Y. Poquet et al., “Foamy macrophages from tuberculous patients' granulomas constitute a nutrient-rich reservoir for M. tuberculosis persistence,” PLoS Pathogens, vol. 4, no. 11, Article ID e1000204, 2008. View at Publisher · View at Google Scholar · View at Scopus
35. D. G. Russell, P. J. Cardona, M. J. Kim, S. Allain, and F. Altare, “Foamy macrophages and the progression of the human tuberculosis granuloma,” Nature Immunology, vol. 10, no. 9, pp. 943–948, 2009. View at Publisher · View at Google Scholar · View at Scopus
36. C. Astarie-Dequeker, E. N. N'Diaye, V. Le Cabec, M. G. Rittig, J. Prandi, and I. Maridonneau-Parini, “The mannose receptor mediates uptake of pathogenic and nonpathogenic mycobacteria and bypasses bactericidal responses in human macrophages,” Infection and Immunity, vol. 67, no. 2, pp. 469–477, 1999. View at Scopus
37. P. Y. Bochud, T. R. Hawn, and A. Aderem, “Cutting edge: a toll-like receptor 2 polymorphism that is associated with lepromatous leprosy is unable to mediate mycobacterial signaling,” Journal of Immunology, vol. 170, no. 7, pp. 3451–3454, 2003. View at Scopus
38. C. S. Hirsch, J. J. Ellner, D. G. Russell, and E. A. Rich, “Complement receptor-mediated uptake and tumor necrosis factor-α-mediated growth inhibition of Mycobacterium tuberculosis by human alveolar macrophages,” Journal of Immunology, vol. 152, no. 2, pp. 743–753, 1994. View at Scopus
39. T. K. Means, S. Wang, E. Lien, A. Yoshimura, D. T. Golenbock, and M. J. Fenton, “Human Toll-like receptors mediate cellular activation by Mycobacterium tuberculosis,” Journal of Immunology, vol. 163, no. 7, pp. 3920–3927, 1999. View at Scopus
40. L. S. Schlesinger, C. G. Bellinger-Kawahara, N. R. Payne, and M. A. Horwitz, “Phagocytosis of Mycobacterium tuberculosis is mediated by human monocyte complement receptors and complement component C3,” Journal of Immunology, vol. 144, no. 7, pp. 2771–2780, 1990. View at Scopus
41. L. S. Schlesinger and M. A. Horwitz, “Phagocytosis of mycobacterium leprae by human monocyte-derived macrophages is mediated by complement receptors CR1 (CD35), CR3 (CD11b/CD18), and CR4 (CD11c/CD18) and IFN-γ activation inhibits complement receptor function and phagocytosis of this bacterium,” Journal of Immunology, vol. 147, no. 6, pp. 1983–1994, 1991. View at Scopus
42. S. Zimmerli, S. Edwards, and J. D. Ernst, “Selective receptor blockade during phagocytosis does not alter the survival and growth of Mycobacterium tuberculosis in human macrophage,” American Journal of Respiratory Cell and Molecular Biology, vol. 15, no. 6, pp. 760–770, 1996. View at Scopus
43. L. Tallieux, O. Schwartz, J.-L. Herrmann et al., “DC-SIGN is the major Mycobacterium tuberculosis receptor on human dendritic cells,” Journal of Experimental Medicine, vol. 197, no. 1, pp. 121–127, 2003. View at Publisher · View at Google Scholar · View at Scopus
44. S. Gordon and F. O. Martinez, “Alternative activation of macrophages: mechanism and functions,” Immunity, vol. 32, no. 5, pp. 593–604, 2010. View at Publisher · View at Google Scholar · View at Scopus
45. J. E. Qualls, G. Neale, A. M. Smith et al., “Arginine usage in mycobacteria-infected macrophages depends on autocrine-paracrine cytokine signaling,” Science Signaling, vol. 3, no. 135, p. ra62, 2010. View at Publisher · View at Google Scholar · View at Scopus
46. D. O. Co, L. H. Hogan, S. I. Kim, and M. Sandor, “Mycobacterial granulomas: keys to a long-lasting host-pathogen relationship,” Clinical Immunology, vol. 113, no. 2, pp. 130–136, 2004. View at Publisher · View at Google Scholar · View at Scopus
47. M. P. Puissegur, G. Lay, M. Gilleron et al., “Mycobacterial lipomannan induces granuloma macrophage fusion via a TLR2-dependent, ADAM9- and β1 integrin-mediated pathway,” Journal of Immunology, vol. 178, no. 5, pp. 3161–3169, 2007. View at Scopus
48. H. Sakai, I. Okafuji, R. Nishikomori et al., “The CD40-CD40L axis and IFN-γ play critical roles in Langhans giant cell formation,” International Immunology, vol. 24, no. 1, pp. 5–15, 2012. View at Publisher · View at Google Scholar · View at Scopus
49. K. Uehira, R. Amakawa, T. Ito et al., “Dendritic cells are decreased in blood and accumulated in granuloma in tuberculosis,” Clinical Immunology, vol. 105, no. 3, pp. 296–303, 2002. View at Publisher · View at Google Scholar · View at Scopus
50. A. Pedroza-Gonzalez, G. S. García-Romo, D. Aguilar-Léon et al., “In situ analysis of lung antigen-presenting cells during murine pulmonary infection with virulent Mycobacterium tuberculosis,” International Journal of Experimental Pathology, vol. 85, no. 3, pp. 135–145, 2004. View at Publisher · View at Google Scholar · View at Scopus
51. A. J. Wolf, B. Linas, G. J. Trevejo-Nuñez et al., “Mycobacterium tuberculosis infects dendritic cells with high frequency and impairs their function in vivo,” Journal of Immunology, vol. 179, no. 4, pp. 2509–2519, 2007. View at Scopus
52. H. A. Schreiber, J. S. Harding, O. Hunt et al., “Inflammatory dendritic cells migrate in and out of transplanted chronic mycobacterial granulomas in mice,” Journal of Clinical Investigation, vol. 121, no. 10, pp. 3902–3913, 2011. View at Publisher · View at Google Scholar · View at Scopus
53. K. A. Bodnar, N. V. Serbina, and J. L. Flynn, “Fate of Mycobacterium tuberculosis within murine dendritic cells,” Infection and Immunity, vol. 69, no. 2, pp. 800–809, 2001. View at Publisher · View at Google Scholar · View at Scopus
54. L. Tailleux, O. Neyrolles, S. Honoré-Bouakline et al., “Constrained intracellular survival of Mycobacterium tuberculosis in human dendritic cells,” Journal of Immunology, vol. 170, no. 4, pp. 1939–1948, 2003. View at Scopus
55. H. D'Avila, R. C. N. Melo, G. G. Parreira, E. Werneck-Barroso, H. C. Castro-Faria-Neto, and P. T. Bozza, “Mycobacterium bovis bacillus Calmette-Guerin induces TLR2-mediated formation of lipid bodies: intracellular domains for eicosanoid synthesis in vivo,” Journal of Immunology, vol. 176, no. 5, pp. 3087–3097, 2006. View at Scopus
56. D. Ordway, M. Henao-Tamayo, I. M. Orme, and M. Gonzalez-Juarrero, “Foamy macrophages within lung granulomas of mice infected with Mycobacterium tuberculosis express molecules characteristic of dendritic cells and antiapoptotic markers of the TNF receptor-associated factor family,” Journal of Immunology, vol. 175, no. 6, pp. 3873–3881, 2005. View at Scopus
57. U. Barros, U. Ladiwala, T. J. Birdi, and N. H. Antia, “Localization and retention of mycobacterial antigen in lymph nodes of leprosy patients,” British Journal of Experimental Pathology, vol. 68, no. 5, pp. 733–741, 1987. View at Scopus
58. H. Muller and S. Kruger, “Immunohistochemical analysis of cell composition and in situ cytokine expression in HIV- and non-HIV-associated tuberculous lymphadenitis,” Immunobiology, vol. 191, no. 4-5, pp. 354–368, 1994. View at Scopus
59. D. D. Riedel and S. H. Kaufmann, “Chemokine secretion by human polymorphonuclear granulocytes after stimulation with Mycobacterium tuberculosis and lipoarabinomannan,” Infection and Immunity, vol. 65, no. 11, pp. 4620–4623, 1997. View at Scopus
60. L. Zhang, D. English, and B. R. Andersen, “Activation of human neutrophils by Mycobacterium tuberculosis-derived sulfolipid-1,” Journal of Immunology, vol. 146, no. 8, pp. 2730–2736, 1991. View at Scopus
61. N. P. Juffermans, S. Florquin, L. Camoglio et al., “Interleukin-1 signaling is essential for host defense during murine pulmonary tuberculosis,” Journal of Infectious Diseases, vol. 182, no. 3, pp. 902–908, 2000. View at Publisher · View at Google Scholar · View at Scopus
62. P. Seiler, P. Aichele, S. Bandermann et al., “Early granuloma formation after aerosol Mycobacterium tuberculosis infection is regulated by neutrophils via CXCR3-signaling chemokines,” European Journal of Immunology, vol. 33, no. 10, pp. 2676–2686, 2003. View at Publisher · View at Google Scholar · View at Scopus
63. R. Appelberg, A. G. Castro, S. Gomes, J. Pedrosa, and M. T. Silva, “Susceptibility of beige mice to mycobacterium avium: role of neutrophils,” Infection and Immunity, vol. 63, no. 9, pp. 3381–3387, 1995. View at Scopus
64. M. C. Tsai, S. Chakravarty, G. Zhu et al., “Characterization of the tuberculous granuloma in murine and human lungs: cellular composition and relative tissue oxygen tension,” Cellular Microbiology, vol. 8, no. 2, pp. 218–232, 2006. View at Publisher · View at Google Scholar · View at Scopus
65. C. H. Ladel, S. Daugelat, and S. H. Kaufmann, “Immune response to mycobacterium bovis bacille Calmette-Guerin infection in major histocompatibility complex class I- and II deficient knock-out mice: contribution of CD4 and CD8 T cells to acquired resistance,” European Journal of Immunology, vol. 25, no. 2, pp. 377–384, 1995. View at Publisher · View at Google Scholar · View at Scopus
66. A. M. Caruso, N. Serbina, E. Klein, K. Triebold, B. R. Bloom, and J. L. Flynn, “Mice deficient in CD4 T cells have only transiently diminished levels of IFN-γ, yet succumb to tuberculosis,” Journal of Immunology, vol. 162, no. 9, pp. 5407–5416, 1999. View at Scopus
67. L. H. Hogan, K. Macvilay, B. Barger et al., “Mycobacterium bovis strain bacillus Calmette-Guerin-induced liver granulomas contain a diverse TCR repertoire, but a monoclonal T cell population is sufficient for protective granuloma formation,” Journal of Immunology, vol. 166, no. 10, pp. 6367–6375, 2001. View at Scopus
68. D. Ordway, D. M. Higgins, J. Sanchez-Campillo et al., “XCL1 (lymphotactin) chemokine produced by activated CD8 T cells during the chronic stage of infection with Mycobacterium tuberculosis negatively affects production of IFN-γ by CD4 T cells and participates in granuloma stability,” Journal of Leukocyte Biology, vol. 82, no. 5, pp. 1221–1229, 2007. View at Publisher · View at Google Scholar · View at Scopus
69. F. Altare, E. Jouanguy, S. Lamhamedi, R. Döffinger, A. Fischer, and J. L. Casanova, “Mendelian susceptibility to mycobacterial infection in man,” Current Opinion in Immunology, vol. 10, no. 4, pp. 413–417, 1998. View at Publisher · View at Google Scholar · View at Scopus
70. C. Fieschi, S. Dupuis, E. Catherinot et al., “Low penetrance, broad resistance, and favorable outcome of interleukin 12 receptor β1 deficiency: medical and immunological implications,” Journal of Experimental Medicine, vol. 197, no. 4, pp. 527–535, 2003. View at Publisher · View at Google Scholar · View at Scopus
71. J. E. Pearl, S. A. Khader, A. Solache et al., “IL-27 signaling compromises control of bacterial growth in mycobacteria-infected mice,” Journal of Immunology, vol. 173, no. 12, pp. 7490–7496, 2004. View at Scopus
72. D. Boselli, G. Losana, P. Bernabei et al., “IFN-γ regulates Fas ligand expression in human CD4⁺ T lymphocytes and controls their anti-mycobacterial cytotoxic functions,” European Journal of Immunology, vol. 37, no. 8, pp. 2196–2204, 2007. View at Publisher · View at Google Scholar · View at Scopus
73. M. Oddo, T. Renno, A. Attinger, T. Bakker, H. R. MacDonald, and P. R. A. Meylan, “Fas ligand-induced apoptosis of infected human macrophages reduces the viability of intracellular Mycobacterium tuberculosis,” Journal of Immunology, vol. 160, no. 11, pp. 5448–5454, 1998. View at Scopus
74. C. L. Silva and D. B. Lowrie, “Identification and characterization of murine cytotoxic T cells that kill Mycobacterium tuberculosis,” Infection and Immunity, vol. 68, no. 6, pp. 3269–3274, 2000. View at Publisher · View at Google Scholar · View at Scopus
75. A. M. Gallegos, J. W. J. van Heijst, M. Samstein, X. Su, E. G. Pamer, and M. S. Glickman, “A gamma interferon independent mechanism of CD4 T cell mediated control of M. tuberculosis infection in vivo,” PLoS Pathogens, vol. 7, no. 5, Article ID e1002052, 2011. View at Publisher · View at Google Scholar · View at Scopus
76. E. Lockhart, A. M. Green, and J. L. Flynn, “IL-17 production is dominated by γδ T cells rather than CD4 T cells during Mycobacterium tuberculosis infection,” Journal of Immunology, vol. 177, no. 7, pp. 4662–4669, 2006. View at Scopus
77. X. Chen, B. Zhou, M. Li et al., “CD4⁺CD25⁺FoxP3⁺ regulatory T cells suppress Mycobacterium tuberculosis immunity in patients with active disease,” Clinical Immunology, vol. 123, no. 1, pp. 50–59, 2007. View at Publisher · View at Google Scholar · View at Scopus
78. J. P. Scott-Browne, S. Shafiani, G. Tucker-Heard et al., “Expansion and function of Foxp3-expressing T regulatory cells during tuberculosis,” Journal of Experimental Medicine, vol. 204, no. 9, pp. 2159–2169, 2007. View at Publisher · View at Google Scholar · View at Scopus
79. J. L. Flynn, M. M. Goldstein, K. J. Triebold, B. Koller, and B. R. Bloom, “Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection,” Proceedings of the National Academy of Sciences of the United States of America, vol. 89, no. 24, pp. 12013–12017, 1992. View at Publisher · View at Google Scholar · View at Scopus
80. C. H. Ladel, C. Blum, A. Dreher, K. Reifenberg, and S. H. Kaufmann, “Protective role of gamma/delta T cells and alpha/beta T cells in tuberculosis,” European Journal of Immunology, vol. 25, no. 10, pp. 2877–2881, 1995.
81. C. H. Ladel, J. Hess, S. Daugelat, P. Mombaerts, S. Tonegawa, and S. H. E. Kaufmann, “Contribution of α/β and γ/δ T lymphocytes to immunity against mycobacterium bovis bacillus Calmette-Guerin: studies with T cell receptor-deficient mutant mice,” European Journal of Immunology, vol. 25, no. 3, pp. 838–846, 1995. View at Publisher · View at Google Scholar · View at Scopus
82. T. Mogues, M. E. Goodrich, L. Ryan, R. LaCourse, and R. J. North, “The relative importance of T cell subsets in immunity and immunopathology of airborne Mycobacterium tuberculosis infection in mice,” Journal of Experimental Medicine, vol. 193, no. 3, pp. 271–280, 2001. View at Publisher · View at Google Scholar · View at Scopus
83. J. Turner, C. D. D'Souza, J. E. Pearl et al., “CD8- and CD95/95L-dependent mechanisms of resistance in mice with chronic pulmonary tuberculosis,” American Journal of Respiratory Cell and Molecular Biology, vol. 24, no. 2, pp. 203–209, 2001. View at Scopus
84. R. E. Tascon, E. Stavropoulos, K. V. Lukacs, and M. J. Colston, “Protection against Mycobacterium tuberculosis infection by CD8⁺ T cells requires the production of gamma interferon,” Infection and Immunity, vol. 66, no. 2, pp. 830–834, 1998. View at Scopus
85. A. M. Cooper, C. D'Souza, A. A. Frank, and I. M. Orme, “The course of Mycobacterium tuberculosis infection in the lungs of mice lacking expression of either perforin- or granzyme-mediated cytolytic mechanisms,” Infection and Immunity, vol. 65, no. 4, pp. 1317–1320, 1997. View at Scopus
86. P. Laochumroonvorapong, J. Wang, C. C. Liu et al., “Perforin, a cytotoxic molecule which mediates cell necrosis, is not required for the early control of mycobacterial infection in mice,” Infection and Immunity, vol. 65, no. 1, pp. 127–132, 1997. View at Scopus
87. A. Lalvani, R. Brookes, and R. J. Wilkinson, “Human cytolytic and interferon gamma-secreting CD8⁺ T lymphocytes specific for Mycobacterium tuberculosis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 1, pp. 270–275, 1998. View at Publisher · View at Google Scholar
88. S. Stenger, D. A. Hanson, R. Teitelbaum et al., “An antimicrobial activity of cytolytic T cells mediated by granulysin,” Science, vol. 282, no. 5386, pp. 121–125, 1998. View at Publisher · View at Google Scholar · View at Scopus
89. C. D. D'Souza, A. M. Cooper, A. A. Frank, R. J. Mazzaccaro, B. R. Bloom, and I. M. Orme, “An anti-inflammatory role for γδ T lymphocytes in acquired immunity to Mycobacterium tuberculosis,” Journal of Immunology, vol. 158, no. 3, pp. 1217–1221, 1997. View at Scopus
90. F. Dieli, J. Ivanyi, P. Marsh et al., “Characterization of lung γδ T cells following intranasal infection with mycobacterium bovis bacillus Calmette-Guerin,” Journal of Immunology, vol. 170, no. 1, pp. 463–469, 2003. View at Scopus
91. Y. Shen, D. Zhou, L. Qiu, et al., “Adaptive immune response of Vgamma2Vdelta2⁺ T cells during mycobacterial infections,” Science, vol. 295, no. 5563, pp. 2255–2258, 2002. View at Publisher · View at Google Scholar
92. D. F. Hoft, R. M. Brown, and S. T. Roodman, “Bacille Calmette-Guerin vaccination enhances human γδ T cell responsiveness to mycobacteria suggestive of a memory-like phenotype,” Journal of Immunology, vol. 161, no. 2, pp. 1045–1054, 1998. View at Scopus
93. A. Salerno and F. Dieli, “Role of γδ T lymphocytes in immune response in humans and mice,” Critical Reviews in Immunology, vol. 18, no. 4, pp. 327–357, 1998. View at Scopus
94. C. H. Ladel, G. Szalay, D. Riedel, and S. H. E. Kaufmann, “Interleukin-12 secretion by Mycobacterium tuberculosis-infected macrophages,” Infection and Immunity, vol. 65, no. 5, pp. 1936–1938, 1997. View at Scopus
95. R. L. Modlin, C. Pirmez, F. M. Hofman et al., “Lymphocytes bearing antigen-specific γδ T-cell receptors accumulate in human infectious disease lesions,” Nature, vol. 339, no. 6225, pp. 544–548, 1989. View at Scopus
96. T. Inoue, Y. Yoshikai, G. Matsuzaki, and K. Nomoto, “Early appearing γ/δ-bearing T cells during infection with Calmette-Guerin Bacillus,” Journal of Immunology, vol. 146, no. 8, pp. 2754–2762, 1991. View at Scopus
97. B. M. Saunders, A. A. Frank, A. M. Cooper, and I. M. Orme, “Role of T cells in immunopathology of pulmonary mycobacterium avium infection in mice,” Infection and Immunity, vol. 66, no. 11, pp. 5508–5514, 1998. View at Scopus
98. M. Umemura, A. Yahagi, S. Hamada et al., “IL-17-mediated regulation of innate and acquired immune response against pulmonary mycobacterium bovis bacille Calmette-Guerin infection,” Journal of Immunology, vol. 178, no. 6, pp. 3786–3796, 2007. View at Scopus
99. D. S. Kim, K. Y. Lee, W. I. Yang, S. J. Han, and E. H. Hwang, “Gamma/Delta T Lymphocytes in the BCG Granulomatous Lesions,” Yonsei Medical Journal, vol. 37, no. 5, pp. 319–324, 1996. View at Scopus
100. B. Falini, L. Flenghi, S. Pileri et al., “Distribution of T cells bearing different forms of the T cell receptor γ/δ in normal and pathological human tissues,” Journal of Immunology, vol. 143, no. 8, pp. 2480–2488, 1989. View at Scopus
101. I. Apostolou, Y. Takahama, C. Belmant et al., “Murine natural killer cells contribute to the granulomatous reaction caused by mycobacterial cell walls,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 9, pp. 5141–5146, 1999. View at Publisher · View at Google Scholar · View at Scopus
102. I. Sugawara, H. Yamada, S. Mizuno, C. Y. Li, T. Nakayama, and M. Taniguchi, “Mycobacterial infection in natural killer T cell knockout mice,” Tuberculosis, vol. 82, no. 2-3, pp. 97–104, 2002. View at Publisher · View at Google Scholar · View at Scopus
103. F. Dieli, M. Taniguchi, M. Kronenberg et al., “An anti-inflammatory role for Vα14 NK T cells in mycobacterium bovis bacillus Calmette-Guerin-infected mice,” Journal of Immunology, vol. 171, no. 4, pp. 1961–1968, 2003. View at Scopus
104. A. Chackerian, J. Alt, V. Perera, and S. M. Behar, “Activation of NKT cells protects mice from tuberculosis,” Infection and Immunity, vol. 70, no. 11, pp. 6302–6309, 2002. View at Publisher · View at Google Scholar · View at Scopus
105. M. J. Kim, H. C. Wainwright, M. Locketz et al., “Caseation of human tuberculosis granulomas correlates with elevated host lipid metabolism,” EMBO Molecular Medicine, vol. 2, no. 7, pp. 258–274, 2010. View at Publisher · View at Google Scholar · View at Scopus
106. H. M. Vordermeier, N. Venkataprasad, D. P. Harris, and J. Ivanyi, “Increase of tuberculous infection in the organs of B cell-deficient mice,” Clinical and Experimental Immunology, vol. 106, no. 2, pp. 312–316, 1996. View at Scopus
107. C. M. Johnson, A. M. Cooper, A. A. Frank, C. B. C. Bonorino, L. J. Wysoki, and I. M. Orme, “Mycobacterium tuberculosis aerogenic rechallenge infections in B cell-deficient mice,” Tubercle and Lung Disease, vol. 78, no. 5-6, pp. 257–261, 1997. View at Scopus
108. P. J. Maglione, J. Xu, and J. Chan, “B cells moderate inflammatory progression and enhance bacterial containment upon pulmonary challenge with Mycobacterium tuberculosis,” Journal of Immunology, vol. 178, no. 11, pp. 7222–7234, 2007. View at Scopus
109. C. M. Bosio, D. Gardner, and K. L. Elkins, “Infection of B cell-deficient mice with CDC 1551, a clinical isolate of Mycobacterium tuberculosis: delay in dissemination and development of lung pathology,” Journal of Immunology, vol. 164, no. 12, pp. 6417–6425, 2000. View at Scopus
110. J. Turner, A. A. Frank, J. V. Brooks, P. M. Marietta, B. Vesosky, and I. M. Orme, “Tuberculosis in aged γδ T cell gene disrupted mice,” Experimental Gerontology, vol. 36, no. 2, pp. 245–254, 2001. View at Publisher · View at Google Scholar · View at Scopus
111. T. Ulrichs, G. A. Kosmiadi, V. Trusov et al., “Human tuberculous granulomas induce peripheral lymphoid follicle-like structures to orchestrate local host defence in the lung,” Journal of Pathology, vol. 204, no. 2, pp. 217–228, 2004. View at Publisher · View at Google Scholar · View at Scopus
112. T. Ulrichs, G. A. Kosmiadi, S. Jörg et al., “Differential organization of the local immune response in patients with active cavitary tuberculosis or with nonprogressive tuberculoma,” Journal of Infectious Diseases, vol. 192, no. 1, pp. 89–97, 2005. View at Publisher · View at Google Scholar · View at Scopus
113. R. T. Russo and M. Mariano, “B-1 cell protective role in murine primary mycobacterium bovis bacillus Calmette-Guerin infection,” Immunobiology, vol. 215, no. 12, pp. 1005–1014, 2010. View at Publisher · View at Google Scholar · View at Scopus
114. S. C. Wong, A. L. Puaux, M. Chittezhath et al., “Macrophage polarization to a unique phenotype driven by B cells,” European Journal of Immunology, vol. 40, no. 8, pp. 2296–2307, 2010. View at Publisher · View at Google Scholar · View at Scopus
115. A. M. Dannenberg Jr., “Delayed-type hypersensitivity and cell-mediated immunity in the pathogenesis of tuberculosis,” Immunology Today, vol. 12, no. 7, pp. 228–233, 1991. View at Scopus
116. A. Fayyazi, B. Eichmeyer, A. Soruri et al., “Apoptosis of macrophages and T cells in tuberculosis associated caseous necrosis,” Journal of Pathology, vol. 191, no. 4, pp. 417–425, 2000. View at Publisher · View at Google Scholar · View at Scopus
117. J. A. Philips and J. D. Ernst, “Tuberculosis pathogenesis and immunity,” Annual Review of Pathology, vol. 7, pp. 353–384, 2012. View at Publisher · View at Google Scholar · View at Scopus
118. S. Aly, K. Wagner, C. Keller et al., “Oxygen status of lung granulomas in Mycobacterium tuberculosis-infected mice,” Journal of Pathology, vol. 210, no. 3, pp. 298–305, 2006. View at Publisher · View at Google Scholar · View at Scopus
119. L. E. Via, P. L. Lin, S. M. Ray et al., “Tuberculous granulomas are hypoxic in guinea pigs, rabbits, and nonhuman primates,” Infection and Immunity, vol. 76, no. 6, pp. 2333–2340, 2008. View at Publisher · View at Google Scholar · View at Scopus
120. S. Aly, T. Laskay, J. Mages, A. Malzan, R. Lang, and S. Ehlers, “Interferon-gamma-dependent mechanisms of mycobacteria-induced pulmonary immunopathology: the role of angiostasis and CXCR3-targeted chemokines for granuloma necrosis,” Journal of Pathology, vol. 212, no. 3, pp. 295–305, 2007. View at Publisher · View at Google Scholar · View at Scopus
121. J. L. Taylor, O. C. Turner, R. J. Basaraba, J. T. Belisle, K. Huygen, and I. M. Ormel, “Pulmonary necrosis resulting from DNA vaccination against tuberculosis,” Infection and Immunity, vol. 71, no. 4, pp. 2192–2198, 2003. View at Publisher · View at Google Scholar · View at Scopus
122. M. Soussan, P.-Y. Brillet, A. Mekinian et al., “Patterns of pulmonary tuberculosis on FDG-PET/CT,” submitted to European Journal of Radiology. View at Publisher · View at Google Scholar
123. M. Sathekge, A. Maes, Y. D'Asseler, M. Vorster, and C. Van De Wiele, “Nuclear medicine imaging in tuberculosis using commercially available radiopharmaceuticals,” Nuclear Medicine Communications, vol. 33, no. 6, pp. 581–590, 2012. View at Publisher · View at Google Scholar · View at Scopus